Tag: Boehringer Ingelheim

Global Survey Reveals Gaps in Pet Parasite Awareness as Prevention Efforts Urged

A global survey released for World Parasite Awareness Day highlights gaps in…

ME Desk

Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGOยฎ

Boehringer Ingelheim and LEO Pharma today announced an exclusive global license and…

ME Desk

Compliance Officer, Boehringer Ingelheim IMETA (India, Middle East, Turkey, Africa)

Hani Hussein is a seasoned compliance leader with over 25 years of…

ME Desk

DoH and Boehringer Ingelheim Ink Strategic Partnership to Advance Life Science Innovation Across the Emirate

The Department of Health โ€“ Abu Dhabi (DoH), the regulator of the…

ME Desk

Boehringer Ingelheim and VSF Germany unite to fight Rabies in Kenya

Ingelheim- December 2024- Having recently signed an agreement to fight rabies in…

ME Desk

Ministry of Health Saudi Arabia and Boehringer Ingelheim Unite for Better Stroke Care

Riyadh, Kingdom of Saudi Arabia- November 2024- Boehringer Ingelheim has signed a…

ME Desk

Boehringer Ingelheim to submit nerandomilast for IPF treatment approval

Ingelheim, Germany- September 2024- Boehringer Ingelheim announced that the FIBRONEERโ„ข-IPF trial met…

ME Desk

Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments

Boehringer Ingelheim and Sosei Group Corporation announced they have entered a global…

ME Desk